LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

计划入组 557 人 · 首次发布于 2021 年 3 月 10 日

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

计划入组 200 人 · 首次发布于 2025 年 7 月 31 日

Beat the Heat Boston

计划入组 100 人 · 首次发布于 2025 年 5 月 21 日

Radiopharmaceutical diagnostics and therapeutics (Fuzionaire Diagnostics)

HuCo Heart

Sepsis(Asylia Diagnostics)

BOSTON SCIENTIFIC

France

BOSTON PHARMACEUTICALS

Kenya

Boston University

United States

Biomerica Appoints Scott Madel as Chief Commercial Officer to Drive inFoods IBS Test Commercialization

Boston Scientific Advances AI-Driven Heart Failure Monitoring with 70% Prediction Accuracy

FDA Issues Safety Alerts for Boston Scientific Heart Devices Linked to 33 Deaths